PWP
ONC

Prasad Wealth Partners’s BeOne Medicines Ltd ONC Stock Holding History

Prasad Wealth Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Hold
1,518
– – 0.1% 97
2026
Q1 		$451K Buy
1,518
+1
+0.1% +$324 0.12% 85
2025
Q4 		$461K Hold
1,517
– – 0.12% 80
2025
Q3 		$517K Buy
+1,517
New +$461K 0.14% 73

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Prasad Wealth Partners's ONC Position: Q2 2026 in Review

Prasad Wealth Partners held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 1,518 shares worth $432K. The position accounts for 0.1% of the portfolio, ranked #97.

Prasad Wealth Partners first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $517K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Prasad Wealth Partners held 1,518 shares of BeOne Medicines Ltd worth $432K as of Q2 2026.
  • Prasad Wealth Partners left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.1% of Prasad Wealth Partners's portfolio in Q2 2026, its #97 holding.
  • Prasad Wealth Partners first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • Prasad Wealth Partners's BeOne Medicines Ltd position peaked at $517K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Prasad Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.